Home Cart 0 Sign in  
X

[ CAS No. 71255-09-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 71255-09-9
Chemical Structure| 71255-09-9
Chemical Structure| 71255-09-9
Structure of 71255-09-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 71255-09-9 ]

Related Doc. of [ 71255-09-9 ]

Alternatived Products of [ 71255-09-9 ]

Product Details of [ 71255-09-9 ]

CAS No. :71255-09-9 MDL No. :MFCD04115112
Formula : C7H7NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :PIFFMIDNNWOQLK-UHFFFAOYSA-N
M.W : 137.14 Pubchem ID :12533391
Synonyms :

Calculated chemistry of [ 71255-09-9 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 36.12
TPSA : 39.19 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.7 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.59
Log Po/w (XLOGP3) : 0.62
Log Po/w (WLOGP) : 0.9
Log Po/w (MLOGP) : -0.08
Log Po/w (SILICOS-IT) : 1.48
Consensus Log Po/w : 0.9

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.39
Solubility : 5.55 mg/ml ; 0.0405 mol/l
Class : Very soluble
Log S (Ali) : -1.02
Solubility : 13.2 mg/ml ; 0.096 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.07
Solubility : 1.16 mg/ml ; 0.00849 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.4

Safety of [ 71255-09-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 71255-09-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 71255-09-9 ]
  • Downstream synthetic route of [ 71255-09-9 ]

[ 71255-09-9 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 124-41-4 ]
  • [ 36404-88-3 ]
  • [ 71255-09-9 ]
YieldReaction ConditionsOperation in experiment
69% for 5 h; Reflux Elemental sodium (0.35 g, 15.0 mmol) was added to dry MeOH (6 mL) at 0 °C and allowed to dissolve completely. A solution of 2-chloronicotinaldehyde (0.708, 5.0 mmol) in dry MeOH (2 mL) was added via syringe and the reaction was heated at reflux temperature for 5 hours. The reaction mixture was cooled to room temperature and evaporated under reduced pressure. The residue was taken up in water (10 mL), neutralized with dilute HCl and extracted with Et2O (3 × 10 mL). The organic extracts were dried (MgSO4), filtered and evaporated under reduced pressure. The residue was purified by flash chromatography (petroleum ether/EtOAc, 4:1) to give the title compound, 8 (0.473, 69percent), as a colorless oil. 1H NMR (300 MHz, CDCl3) δ 10.34 (d, J = 0.8 Hz, 1H), 8.36 (dd, J = 4.9, 2.1 Hz, 1H), 8.09 (dd, J = 7.4, 2.1 Hz, 1H), 7.00 (ddd, J = 7.4, 4.9, 0.8 Hz, 1H), 4.07 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 189.1, 164.4, 152.8, 137.6, 118.8, 117.3, 54.0
Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 14, p. 3933 - 3937
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1990, # 9, p. 2409 - 2415
  • 2
  • [ 13472-59-8 ]
  • [ 68-12-2 ]
  • [ 71255-09-9 ]
Reference: [1] Synthesis, 2012, vol. 44, # 5, p. 735 - 746
  • 3
  • [ 1628-89-3 ]
  • [ 68-12-2 ]
  • [ 71255-09-9 ]
Reference: [1] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1292 - 1304
[2] Journal of Organic Chemistry, 1990, vol. 55, # 1, p. 69 - 73
[3] Tetrahedron Letters, 1988, vol. 29, # 7, p. 773 - 776
  • 4
  • [ 109-09-1 ]
  • [ 71255-09-9 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1990, # 9, p. 2409 - 2415
[2] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 14, p. 3933 - 3937
  • 5
  • [ 1628-89-3 ]
  • [ 109-72-8 ]
  • [ 68-12-2 ]
  • [ 71255-09-9 ]
  • [ 112219-56-4 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 7, p. 1367 - 1371
  • 6
  • [ 1628-89-3 ]
  • [ 68-12-2 ]
  • [ 71255-09-9 ]
  • [ 112219-56-4 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 7, p. 1367 - 1371
  • 7
  • [ 1628-89-3 ]
  • [ 109-94-4 ]
  • [ 71255-09-9 ]
  • [ 112219-56-4 ]
  • [ 71255-10-2 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 7, p. 1367 - 1371
  • 8
  • [ 2591-86-8 ]
  • [ 1628-89-3 ]
  • [ 71255-09-9 ]
Reference: [1] Journal of Organometallic Chemistry, 1991, vol. 406, # 1+2, p. 49 - 56
  • 9
  • [ 71255-09-9 ]
  • [ 112197-16-7 ]
YieldReaction ConditionsOperation in experiment
99% With sodium tetrahydroborate In tetrahydrofuran at 20℃; for 1 h; Step 1: (2-Methoxypyridin-3-yl)methanoI To a solution of 2-methoxy-pyridine-3-carbaldehyde (2.03 g, 14.8 mmol) in THF (35 mL) was added sodium tetrahydroborate (617 mg, 16.3 mmol) at rt and the mixture was stirred for 1 h. The mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over Na S04 and concentrated. The crude product was purified on silica gel to give (2- methoxypyridin-3-yl)methanol (2.05 g, 99percent) as a clear oil. LCMS (FA): m/z = 140 (M+H).
94% With sodium tetrahydroborate In ethanol at -40℃; for 0.75 h; Inert atmosphere Sodium borohydride (0.17 g, 4.5 mmol) was dissolved in 20 ml ethanol under argon and the mixture cooled to -40 °C in a cryo-cool.
A solution of 2-methoxynicotinaldehyde (2.0 g, 14.6 mmol) dissolved in 4 ml ethanol was added drop-wise and with stirring.
The mixture was stirred at -40 °C for 45 min. 10 ml Brine was added carefully and the mixture was then allowed to warm to room temperature.
The organics were evaporated under reduced pressure.
The mixture was partitioned between ethyl acetate and water.
The aqueous phase was extracted with ethyl acetate and the combined organics were dried over magnesium sulphate, filtered and evaporated to give 44 (1.90 g, 13.7 mmol, 94percent yield) as a pale yellow oil.
Purity 100percent. 1H NMR (300 MHz, CDCl3) δ ppm 2.30 (t, J = 6.5 Hz, 1H, OH), 4.00 (s, 3H, MeO), 4.66 (d, J = 6.3 Hz, 2H, CH2), 6.90 (dd, J = 5.0, 7.1 Hz, 1H, H-5), 7.58 (d, J = 7.1 Hz, 1H, H-4), 8.11 (d, J = 4.9 Hz, 1H, H-6). UPLC/MS (3 min) retention time 0.77 min. LRMS: m/z 140 (M+1).
Reference: [1] Patent: WO2015/2994, 2015, A2, . Location in patent: Paragraph 00194
[2] European Journal of Medicinal Chemistry, 2016, vol. 113, p. 102 - 133
[3] Patent: US2008/103129, 2008, A1, . Location in patent: Page/Page column 47
[4] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 1, p. 405 - 408
  • 10
  • [ 71255-09-9 ]
  • [ 354824-19-4 ]
YieldReaction ConditionsOperation in experiment
69%
Stage #1: With ammonium acetate; sodium cyanoborohydride In methanol for 48 h;
Stage #2: With hydrogenchloride In water
Example 11: Synthesis of 3-aminomethyl-2-methoxypyridine EPO <DP n="34"/>24 25[00102] A round bottom flask was charged with 0.44g (3.23mM) of 2-methoxy-3- pyridine carboxaldehyde (24), 1.24g (16.15mM) of ammonium acetate, and 0.61g (19.69mM) of sodium cyanoborohydride. The flask was then flushed with argon, and then 5OmL of dry MeOH was added by syringe. The reaction was stirred for 2 days, at which point the MeOH was evaporated off. 25mL of water was added, and the mixture was brought to pH 2 with cone. HCl. This was extracted twice with EtOAc to remove the alcohol side product. The mixture was brought to pH 10 using sodium hydroxide pellets, saturated with NaCl, and extracted twice with DCM and once with EtOAc. The combined organics were dried and evaporated to give 0.3 Ig (69percent) of 3-aminomethyl-2- methoxypyridine (25).
69%
Stage #1: With ammonium acetate; sodium cyanoborohydride In methanol for 48 h;
Stage #2: With hydrogenchloride; water In methanol
Stage #3: With sodium hydroxide; water In methanol
Example 11
Synthesis of 3-aminomethyl-2-methoxypyridine
A round bottom flask was charged with 0.44 g (3.23 mM) of 2-methoxy-3-pyridine carboxaldehyde (24), 1.24 g (16.15 mM) of ammonium acetate, and 0.61 g (19.69 mM) of sodium cyanoborohydride.
The flask was then flushed with argon, and then 50 mL of dry MeOH was added by syringe.
The reaction was stirred for 2 days, at which point the MeOH was evaporated off.
25 mL of water was added, and the mixture was brought to pH 2 with conc. HCl.
This was extracted twice with EtOAc to remove the alcohol side product.
The mixture was brought to pH 10 using sodium hydroxide pellets, saturated with NaCl, and extracted twice with DCM and once with EtOAc.
The combined organics were dried and evaporated to give 0.31 g (69percent) of 3-aminomethyl-2-methoxypyridine (25).
69% With ammonium acetate; sodium cyanoborohydride In methanol for 48 h; A round bottom flask was charged with 0.44g (3.23mM) of 2-methoxy-3-pyridine carboxaldehyde (24), 1.24g (16.15mM) of ammonium acetate, and 0.61g (19.69mM) of sodium cyanoborohydride. The flask was then flushed with argon, and then 5OmL of dry MeOH was added by syringe. The reaction was stirred for 2 days, at which point the MeOH was evaporated off. 25mL of water was added, and the mixture was brought to pH 2 with cone. HCl. This was extracted twice with EtOAc to remove the alcohol side product. The mixture was brought to pH 10 using sodium hydroxide pellets, saturated with NaCl, and extracted twice with DCM and once with EtOAc. The combined organics were dried and evaporated to give 0.31g (69percent) of 3-aminomethyl-2-methoxypyπdine (25).
Reference: [1] Patent: WO2006/108103, 2006, A1, . Location in patent: Page/Page column 32
[2] Patent: US2008/119496, 2008, A1, . Location in patent: Page/Page column 11
[3] Patent: WO2008/60301, 2008, A1, . Location in patent: Page/Page column 31
  • 11
  • [ 71255-09-9 ]
  • [ 942060-13-1 ]
Reference: [1] Patent: WO2015/2994, 2015, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 71255-09-9 ]

Aldehydes

Chemical Structure| 885278-10-4

[ 885278-10-4 ]

2-Isopropoxynicotinaldehyde

Similarity: 0.91

Chemical Structure| 72716-87-1

[ 72716-87-1 ]

2-Methoxyisonicotinaldehyde

Similarity: 0.86

Chemical Structure| 888499-98-7

[ 888499-98-7 ]

5-Cyclopropyl-2-methoxynicotinaldehyde

Similarity: 0.85

Chemical Structure| 95652-81-6

[ 95652-81-6 ]

6-Chloro-2-methoxynicotinaldehyde

Similarity: 0.84

Chemical Structure| 351410-62-3

[ 351410-62-3 ]

5-Fluoro-2-methoxypyridine-3-carboxaldehyde

Similarity: 0.84

Ethers

Chemical Structure| 885278-10-4

[ 885278-10-4 ]

2-Isopropoxynicotinaldehyde

Similarity: 0.91

Chemical Structure| 72716-87-1

[ 72716-87-1 ]

2-Methoxyisonicotinaldehyde

Similarity: 0.86

Chemical Structure| 16498-81-0

[ 16498-81-0 ]

2-Methoxynicotinic acid

Similarity: 0.85

Chemical Structure| 888499-98-7

[ 888499-98-7 ]

5-Cyclopropyl-2-methoxynicotinaldehyde

Similarity: 0.85

Chemical Structure| 351410-62-3

[ 351410-62-3 ]

5-Fluoro-2-methoxypyridine-3-carboxaldehyde

Similarity: 0.84

Related Parent Nucleus of
[ 71255-09-9 ]

Pyridines

Chemical Structure| 885278-10-4

[ 885278-10-4 ]

2-Isopropoxynicotinaldehyde

Similarity: 0.91

Chemical Structure| 72716-87-1

[ 72716-87-1 ]

2-Methoxyisonicotinaldehyde

Similarity: 0.86

Chemical Structure| 16498-81-0

[ 16498-81-0 ]

2-Methoxynicotinic acid

Similarity: 0.85

Chemical Structure| 888499-98-7

[ 888499-98-7 ]

5-Cyclopropyl-2-methoxynicotinaldehyde

Similarity: 0.85

Chemical Structure| 351410-62-3

[ 351410-62-3 ]

5-Fluoro-2-methoxypyridine-3-carboxaldehyde

Similarity: 0.84